| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fe0aaf2231e08ed07d540afabcb9b7b9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1098
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1094
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1095 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-0095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 |
| filingDate |
2017-03-29^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-12-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_000a40b2cdb4e38af05ca5a06c14774c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4839e8e59bb939182275f0a352e20e0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23cb28b5e6697dd1d094d51f2344ff17 |
| publicationDate |
2018-12-01^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-I642437-B |
| titleOfInvention |
Application of compound containing <sup> 10 </ sup> B in preparation and specific binding of β-amyloid protein |
| abstract |
Application of a compound containing 10 B in the preparation of a medicament specifically binding to amyloid β, the medicament specifically binding to amyloid β can be emitted in a neutron capture therapy device after binding amyloid β Neutron beam irradiation reduces or eliminates amyloid beta to further treat Alzheimer's disease. The invention provides a new method for the treatment of Alzheimer's disease. |
| priorityDate |
2016-04-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |